Acrodermatitis chronica atrophicans: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{RT}} | ||
{{SK}} Pick-Herxheimer disease; ACA | {{SK}} Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA | ||
==[[Acrodermatitis chronica atrophicans overview|Overview]]== | ==[[Acrodermatitis chronica atrophicans overview|Overview]]== | ||
Revision as of 19:17, 19 December 2012
For patient information, click here
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans |
|
Risk calculators and risk factors for Acrodermatitis chronica atrophicans |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Synonyms and keywords: Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acrodermatitis chronica atrophicans from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies